AspirinPlatelet Aggregation InhibitorsTrigger Finger DisorderTiclopidineArthrodesisPlatelet Function TestsPlatelet AggregationMedication AdherencePurinergic P2Y Receptor AntagonistsMedication ErrorsReceptors, Purinergic P2Y12Drug Therapy, CombinationHemorrhageBlood PlateletsAnti-Inflammatory Agents, Non-SteroidalTreatment OutcomeThrombosisThiophenesAcute Coronary SyndromePlatelet ActivationMedication ReconciliationMedication SystemsAnticoagulantsMedication Systems, HospitalAngioplasty, Balloon, CoronaryFibrinolytic AgentsMyocardial InfarctionRisk FactorsCoronary ThrombosisStentsProspective StudiesThromboxane B2Double-Blind MethodTime FactorsDrug InteractionsBleeding TimeDrug ResistanceStrokePostoperative HemorrhageDipyridamolePlatelet Glycoprotein GPIIb-IIIa ComplexWarfarinAryl Hydrocarbon HydroxylasesFollow-Up StudiesDose-Response Relationship, DrugCyclooxygenase InhibitorsDrug PrescriptionsProton Pump InhibitorsRetrospective StudiesCoronary Artery DiseaseDrug Administration ScheduleRisk AssessmentPurinergic P2 Receptor AntagonistsAdenosine DiphosphatePatient ComplianceSelf MedicationThienopyridinesDrug-Eluting StentsPrescription DrugsRecurrenceSalicylatesDrug UtilizationRandomized Controlled Trials as TopicPiperazinesPolypharmacyDrug TherapyUnited StatesAdministration, OralGastrointestinal HemorrhageCardiovascular DiseasesPsychotropic DrugsCohort StudiesAntihypertensive AgentsPercutaneous Coronary InterventionDrug CostsThrombelastographySecondary PreventionPhenprocoumonCardiovascular AgentsTetrazolesDrug MonitoringNonprescription DrugsPremedicationCross-Over StudiesDrug-Related Side Effects and Adverse ReactionsThromboembolismCoronary DiseaseAntipsychotic AgentsPhysician's Practice PatternsP-SelectinPlatelet CountTablets, Enteric-CoatedThromboxanesPharmacogeneticsHeparinPerioperative CareHydroxymethylglutaryl-CoA Reductase InhibitorsGraft Occlusion, VascularIncidenceLogistic Models